Carbohydrate Antigen (CA 19-9) Blood Test

• If you have been diagnosed with certain gastrointestinal cancers, such as pancreatic, gastric, colorectal, or biliary tract cancers, and your healthcare provider needs to monitor the disease's progression.
• When you are undergoing treatment for these cancers, to help your doctor assess the effectiveness of the therapy.
• If your healthcare provider suspects recurrence of these specific cancers after previous treatment.

• Individuals who have been diagnosed with certain gastrointestinal cancers, such as pancreatic, gastric, colorectal, or biliary tract cancers, to monitor disease progression or recurrence.
• Patients undergoing treatment for these cancers, as CA 19-9 levels can help assess the effectiveness of therapy.
• Those being monitored for disease recurrence after successful treatment of these specific cancers.

The Carbohydrate Antigen (CA 19-9) test is primarily utilized as a tumor marker for the monitoring and management of certain gastrointestinal cancers, rather than for initial diagnosis or screening in asymptomatic individuals. It is commonly used in contexts related to:

• Pancreatic Cancer: For monitoring disease progression, recurrence, and response to treatment.
• Gastric (Stomach) Cancer: To track disease activity and treatment effectiveness.
• Colorectal Cancer: In specific cases, for monitoring and managing the disease.
• Biliary Tract Cancers (e.g., Cholangiocarcinoma): To monitor disease course and treatment response.

It helps healthcare providers track the status of these malignancies, assess the efficacy of therapeutic interventions, and identify potential disease recurrence after treatment. The results should always be interpreted in conjunction with other clinical findings, imaging, and patient history.

It's important to understand that the CA 19-9 test is primarily used for monitoring certain conditions and is generally not recommended for routine cancer screening or early detection, especially for pancreatic cancer, in individuals without symptoms. Levels can also be influenced by factors like your blood group (Lewis antigen status) or liver conditions. Your results should always be interpreted by a healthcare provider in the context of your complete medical history and other diagnostic findings.